Applied Therapeutics Operating Margin vs. Shares Owned By Institutions

APLT Stock  USD 2.03  6.54  76.31%   
Based on Applied Therapeutics' profitability indicators, Applied Therapeutics may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Applied Therapeutics' ability to earn profits and add value for shareholders. Price To Sales Ratio is likely to drop to 22.59 in 2024. Days Sales Outstanding is likely to drop to 8.33 in 2024. At this time, Applied Therapeutics' Accumulated Other Comprehensive Income is comparatively stable compared to the past year. Net Interest Income is likely to gain to about 1.4 M in 2024, despite the fact that Net Loss is likely to grow to (113.8 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.770.87
Fairly Down
Slightly volatile
For Applied Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Applied Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Applied Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Applied Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Applied Therapeutics over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied Therapeutics. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.42)
Revenue Per Share
(0)
Quarterly Revenue Growth
(0.98)
Return On Assets
(0.76)
Return On Equity
(4.73)
The market value of Applied Therapeutics is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Applied Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied Therapeutics' market value can be influenced by many factors that don't directly affect Applied Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Applied Therapeutics Shares Owned By Institutions vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Applied Therapeutics's current stock value. Our valuation model uses many indicators to compare Applied Therapeutics value to that of its competitors to determine the firm's financial worth.
Applied Therapeutics is rated below average in operating margin category among its peers. It is rated fourth in shares owned by institutions category among its peers . At this time, Applied Therapeutics' Operating Profit Margin is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Applied Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Applied Shares Owned By Institutions vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Applied Therapeutics

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
(243.80) %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Applied Therapeutics

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
94.77 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

Applied Shares Owned By Institutions Comparison

Applied Therapeutics is currently under evaluation in shares owned by institutions category among its peers.

Applied Therapeutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Applied Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Applied Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Applied Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Applied Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income45.9 K48.2 K
Net Interest Income1.4 M1.4 M
Interest Income1.4 M1.1 M
Operating Income-64.5 M-67.8 M
Net Loss-119.8 M-113.8 M
Income Before Tax-119.8 M-113.8 M
Total Other Income Expense Net-55.2 M-52.5 M
Net Loss-95 M-90.3 M
Net Loss-119.8 M-113.8 M
Income Tax Expense185.1 K252.2 K
Non Operating Income Net Other-48.6 K-51 K
Change To Netincome12.4 M6.8 M
Net Loss(1.42)(1.49)
Income Quality 0.46  0.84 
Net Income Per E B T 1.14  1.09 

Applied Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Applied Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Applied Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Applied Therapeutics' important profitability drivers and their relationship over time.

Use Applied Therapeutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Applied Therapeutics Pair Trading

Applied Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to Applied Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied Therapeutics to buy it.
The correlation of Applied Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Applied Therapeutics position

In addition to having Applied Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Thematic Idea Now

Healthcare
Healthcare Theme
Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.